Summary of neoantigens
Neoantigen numbers of each cohort/subtype and neoantigen number of different survival conditions.
Diseases / Subtypes Neoantigens 0~6 months 6~12 months 1~3 years 3~5 years >5 years
Glioma (Cohort1) 4091 983 575 1981 407 190
Glioblastoma 2223 757 361 970 117 17
Astrocytoma 768 91 103 418 111 45
Oligodendroglioma 569 55 38 281 112 83
Oligoastrocytoma 342 20 62 180 41 39
IDH Mutant 1392 160 95 681 285 171
IDH Mutant 1p19q Co-deletion 515 58 29 278 85 65
IDH Mutant 1p19q Non-co-deletion 878 102 66 404 200 106
G-CIMP High 752 91 48 326 181 106
G-CIMP Low 114 11 18 74 11 0
IDH Wild Type 2649 789 480 1273 118 19
Classic 913 222 147 485 50 9
Mesenchymal 834 262 182 356 19 15
Neural 460 66 54 245 56 39
Proneural 1049 169 94 502 174 110
Classic Like 973 278 125 529 37 4
Mesenchymal Like 1134 408 233 467 26 0
PA Like 129 5 2 115 5 2
LGm6 GBM 121 16 53 38 14 0
IDH Wild Type Primary GBM 2132 714 356 896 97 17
Glioma (Cohort2) 206 —— —— —— —— ——
Glioma (Cohort3) 97 —— —— —— —— ——
Lung Cancer (Cohort4) 2619 —— —— —— —— ——
Melanoma (Cohort4) 21108 —— —— —— —— ——
Bladder (Cohort4) 1250 —— —— —— —— ——
HNSCC (Cohort4) 313 —— —— —— —— ——

Select your interest dataset.

Glioma (Cohort1)

4091 Neoantigens

Glioma (Cohort2)

206 Neoantigens

Glioma (Cohort3)

97 Neoantigens

Lung Cancer (Cohort4)

2619 Neoantigens

Bladder (Cohort4)

1250 Neoantigens

Melanoma (Cohort4)

21108 Neoantigens

HNSCC (Cohort4)

313 Neoantigens

Select your interest subtype of Glioma(TCGA) in the rectangle treemap

This rectangle treemap shows the distribution of glioma subtypes under different classification standards. The specific data of 20 different glioma types can be obtained by clicking the corresponding non-italicized characters of the treemap.

Summary of Glioma(TCGA) Different Subtypes
Neoantigens' quantity of different subtypes in five survival periods.
HLA with highest binding-neoantigens' quantity of different subtypes.The frequency of neoantigens decreased from upper to bottom, and the frequency of HLA allele decreased from left to right. The left top corner shows the HLAs with top binding capacity to neoantigens for glioma.
Neoantigens' mutant peptide score of different subtypes. All the scores are calculated by NetMHCPan 4.0.
D-value between neoantigens' wild peptide score and mutant peptide score of different subtypes. All the scores are calculated by NetMHCPan 4.0.